PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $550,890 | -15.6% | 750,000 | 0.0% | 0.00% | -20.0% |
Q4 2022 | $652,410 | -1.7% | 750,000 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $664,000 | +2.8% | 750,000 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $646,000 | -2.7% | 750,000 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $664,000 | -3.3% | 750,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $687,000 | +3.8% | 750,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $662,000 | -1.2% | 750,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $670,000 | -0.3% | 750,000 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $672,000 | +3.2% | 750,000 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $651,000 | +5.3% | 750,000 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $618,000 | +2.0% | 750,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $606,000 | +22.9% | 750,000 | 0.0% | 0.01% | +25.0% |
Q1 2020 | $493,000 | -8.0% | 750,000 | 0.0% | 0.00% | +33.3% |
Q4 2019 | $536,000 | -79.6% | 750,000 | -80.0% | 0.00% | -82.4% |
Q3 2019 | $2,629,000 | -18.8% | 3,750,000 | -21.1% | 0.02% | -19.0% |
Q2 2019 | $3,238,000 | – | 4,750,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PenderFund Capital Management Ltd. | 20,060,000 | $23,311,000 | 5.66% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 44,492,000 | $39,153,000 | 1.56% |
UBS OCONNOR LLC | 26,000,000 | $23,448,000,000 | 0.34% |
Saltoro Capital, LP | 750,000 | $678,000 | 0.17% |
AQR Arbitrage LLC | 3,050,000 | $2,758,000 | 0.10% |
WATER ISLAND CAPITAL LLC | 1,500,000 | $1,371,000 | 0.08% |
PALISADE CAPITAL MANAGEMENT, LP | 3,448,000 | $3,103,000 | 0.07% |
OAKTREE CAPITAL MANAGEMENT LP | 5,780,000 | $5,227,000 | 0.07% |
Teton Advisors, Inc. | 400,000 | $358,000 | 0.05% |
MACQUARIE GROUP LTD | 8,175,000 | $7,393,000 | 0.01% |